KLRA Kailera Therapeutics, Inc.
Company Analysis
Latest News
🔴 Kailera Therapeutics falls 4.0% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🔴 Kailera Therapeutics is trading 4.8% down in after-hours trading
Kailera Therapeutics is trading at $11.15, down 4.78%; no verified October 15 company announcement or reliable report identified a specific after-hours...
🟢 Kailera Therapeutics is trading 4.3% up
Kailera Therapeutics is trading at $11.20, up 4.28% on October 15, 2026; the reason for the gain remains unclear. - No fresh company announcement or reliable...
🟢 Kailera Therapeutics is trading 7% up on October 13, 2026, in after-hours trading — no confirmed catalyst
Kailera Therapeutics is trading at $11.53, up 7.06%, with no company-specific announcement or confirmed catalyst for the after-hours rise identified in...
🔴 Kailera Therapeutics is trading 4.02% down today amid biotech-sector weakness
Kailera Therapeutics is trading at $10.88, down -4.02%, amid biotech-sector weakness; no company-specific catalyst has been confirmed. - The latest listed...
🔴 Kailera Therapeutics is trading 4.7% down with no confirmed catalyst
Kailera Therapeutics is trading 4.7% down at $11.06; no clear company-specific announcement explaining the October 12 move surfaced. - The latest listed...
🟢 Kailera Therapeutics is trading 6% up in pre-market
Kailera Therapeutics is trading at $12.28, up +5.77% in pre-market on October 12, 2026, with no clear company-specific announcement explaining the move. - Its...
🟢 Kailera Therapeutics is trading 10.3% up today amid a biotech-sector rally
Kailera Therapeutics is trading at $11.03, up 10.30%, alongside a biotech-sector rally; no confirmed company-specific catalyst was identified for October 9. -...
🟢 Kailera Therapeutics is trading 4.41% up
Kailera Therapeutics is trading at $10.44, up 4.41%, in morning trading on October 9, 2026; available search found no specific catalyst. - Recent coverage...
🔴 Kailera Therapeutics is trading 4.04% down
Kailera Therapeutics is trading 4.04% down at $10.11, with no specific catalyst confirmed. - No company announcement dated October 8 clearly explains the...
🔴 Kailera Therapeutics is trading 7.75% down in pre-market
Kailera Therapeutics is trading 7.75% down at $10.00 in pre-market on October 6, with no new company announcement or other clear catalyst identified for the...
🟢 Kailera Therapeutics is trading 12% up in pre-market; no clear catalyst confirmed
Kailera Therapeutics is trading 11.98% up at $12.14 in pre-market, with no clear catalyst identified. - Latest reported updates were Phase 1 data presented...
🟢 Kailera Therapeutics is trading 4.04% up with no identified company-specific catalyst
Kailera Therapeutics is trading at $10.81, up +4.04%, with no clear company-specific announcement identified to explain the October 5 move. - The broad market...
🔴 Kailera Therapeutics is trading 4.72% down
Kailera Therapeutics is trading 4.72% down at $9.90 on October 5, 2026, extending a recent slide; no clearly reported same-day catalyst was identified. -...
🔴 Kailera Therapeutics is trading 4.17% down; no specific catalyst established
Kailera Therapeutics is trading 4.17% down at $10.57, with no specific catalyst established. - No verified company-specific news has been linked to the October...
🟢 Kailera Therapeutics is trading 5.6% up in pre-market; no verified company-specific catalyst linked
Kailera Therapeutics is trading at $11.65, up 5.62%, with no verified company-specific catalyst linked to the October 2 pre-market rise. - Kailera announced...
🔴 Kailera Therapeutics is trading 4.8% down
Kailera Therapeutics is trading 4.8% lower at $10.87; no verified source links the decline to a specific catalyst. - The move follows a 3.91% gain on...
🟢 Kailera Therapeutics Surges 4.1% on Completion of Phase 3 Enrollment for Obesity Drug
Kailera Therapeutics is trading at $11.44, up 4.1%, following a significant company announcement. * On September 30, the company announced the completion of...
🟢 Kailera Therapeutics is trading 5% up in pre-market — no clear catalyst identified
Kailera Therapeutics is trading at $11.73, up 5.46%, with no clear company-specific announcement identified to explain its September 29 pre-market rise. - Its...
🔴 Kailera Therapeutics is trading 4.47% down today
Kailera Therapeutics is trading 4.47% lower at $11.45; the catalyst remains unconfirmed. - The shares fell from the September 24 close of $11.98. - No new...